Human Growth Hormone

Human Growth Hormone

• Home
• What is HGH?
• Search
• Syndicate
• More Health

See Also

Human Growth Hormone > Somatropin > Ireland

Please select a HGH news story from the list below:

• Business Wire - An Essential Competitor Analysis Report on Human Growth Hormones : Biosimilar Pricing is Not Enough, Convenience Will Mandate
• Business Wire - Research and Markets: If the Biosimilar Industry is Going to Progress beyond the First Generation Biologics Then It Needs to Target More High Profile Therapies
• Business Wire - Research and Markets: This New Strategic Analysis Report "Novo Nordisk: Performance, Products, Pipeline And Potential" Provides a Complete and...
• Business Wire - Tercica Announces Agreement with Genentech for Worldwide Growth Hormone and IGF-1 Combination Product Development and Commercialization
• Business Wire - To Date, Only One Recognisably Biosimilar Drug, Human Growth Hormone, Has Appeared in Developed Markets: Will a Significant Biosimilar Market Develop?
• Business Wire - Injectable Generic Drugs: Prospects and Opportunities to 2010
• Business Wire - Combined Sales of the Non-Biological Injectables Included in This Study Were in the Region of US$16.5 Billion in 2005, of Which around US$5.5 Billion Will Lose...
• Business Wire - A Number of High Value Drugs due to Come off Patent in the USA and Europe over the next few years are Injectable

Business Wire - An Essential Competitor Analysis Report on Human Growth Hormones : Biosimilar Pricing is Not Enough, Convenience Will Mandate

October 8, 2008 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/6c5438/competitor_analysi) has announced the addition of the...

• Business Wire - An Essential Competitor Analysis Report on Human Growth Hormones : Biosimilar Pricing is Not Enough, Convenience Will Mandate

Business Wire - Research and Markets: If the Biosimilar Industry is Going to Progress beyond the First Generation Biologics Then It Needs to Target More High Profile Therapies

October 26, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c72832) has announced the addition of new report from Espicom...

• Business Wire - Research and Markets: If the Biosimilar Industry is Going to Progress beyond the First Generation Biologics Then It Needs to Target More High Profile Therapies

Business Wire - Research and Markets: This New Strategic Analysis Report "Novo Nordisk: Performance, Products, Pipeline And Potential" Provides a Complete and...

August 1, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c64451) has announced the addition of Espicom Business...

• Business Wire - Research and Markets: This New Strategic Analysis Report "Novo Nordisk: Performance, Products, Pipeline And Potential" Provides a Complete and...

Business Wire - Tercica Announces Agreement with Genentech for Worldwide Growth Hormone and IGF-1 Combination Product Development and Commercialization

July 10, 2007 -- Combination Products for the Potential Treatment of Short Stature and Adult Growth Hormone Deficiency Tercica May Receive up to $53 Million in...

• Business Wire - Tercica Announces Agreement with Genentech for Worldwide Growth Hormone and IGF-1 Combination Product Development and Commercialization

Business Wire - To Date, Only One Recognisably Biosimilar Drug, Human Growth Hormone, Has Appeared in Developed Markets: Will a Significant Biosimilar Market Develop?

September 13, 2006 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c42003) has announced the addition of Espicom Business Analysis's...

• Business Wire - To Date, Only One Recognisably Biosimilar Drug, Human Growth Hormone, Has Appeared in Developed Markets: Will a Significant Biosimilar Market Develop?

Business Wire - Injectable Generic Drugs: Prospects and Opportunities to 2010

April 28, 2006 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c30418) has announced the addition of Injectable Generic Drugs:...

• Business Wire - Injectable Generic Drugs: Prospects and Opportunities to 2010

Business Wire - Combined Sales of the Non-Biological Injectables Included in This Study Were in the Region of US$16.5 Billion in 2005, of Which around US$5.5 Billion Will Lose...

April 26, 2006 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c30418) has announced the addition of Espicom Business...

• Business Wire - Combined Sales of the Non-Biological Injectables Included in This Study Were in the Region of US$16.5 Billion in 2005, of Which around US$5.5 Billion Will Lose...

Business Wire - A Number of High Value Drugs due to Come off Patent in the USA and Europe over the next few years are Injectable

January 6, 2006 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c30418) has announced the addition of Injectable Generic Drugs:...

• Business Wire - A Number of High Value Drugs due to Come off Patent in the USA and Europe over the next few years are Injectable

City

dublin

Countries

ireland united states

Products

espicom business injectable generic drugs